CoreCap Advisors’s Health Catalyst HCAT Stock Holding History

CoreCap Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2	Closed	-$7	–	2957
2025 Q1	$7	Buy	+2	New	+$11	﹤0.01%	3125
2024 Q4	–	Sell	-647	Closed	-$5.27K	–	2911
2024 Q3	$5.27K	Hold	647	–	–	﹤0.01%	1964
2024 Q2	$4.13K	Buy	+647	New	+$4.15K	﹤0.01%	1199
2022 Q3	–	Sell	-120	Closed	-$2K	–	1166
2022 Q2	$2K	Buy	+120	New	+$2.05K	﹤0.01%	1863
2022 Q1	–	Sell	-120	Closed	-$5K	–	1172
2021 Q4	$5K	Buy	+120	New	+$5.47K	﹤0.01%	1747

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CoreCap Advisors's HCAT Position: Q2 2025 in Review

CoreCap Advisors sold out of Health Catalyst (HCAT) in Q2 2025, closing a stake of 2 shares — an estimated $7 sold.

CoreCap Advisors first reported a position in HCAT in Q4 2021 and held it in 5 quarters. The position peaked at $5.27K in Q3 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q2 2025.

CoreCap Advisors reported no remaining Health Catalyst position as of Q2 2025 after selling out during the quarter.
CoreCap Advisors sold 2 Health Catalyst shares in Q2 2025, an estimated $7.
CoreCap Advisors first reported a position in Health Catalyst in Q4 2021 and held it in 5 quarters.
CoreCap Advisors's Health Catalyst position peaked at $5.27K in Q3 2024.
145 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2025.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.